Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy

被引:30
|
作者
Wu, Katherine C. [1 ]
Wongvibulsin, Shannon [2 ,3 ]
Tao, Susumu [1 ]
Ashikaga, Hiroshi [1 ,2 ,3 ]
Stillabower, Michael [5 ]
Dickfeld, Timm M. [6 ]
Marine, Joseph E. [1 ]
Weiss, Robert G. [1 ,4 ]
Tomaselli, Gordon F. [7 ,8 ]
Zeger, Scott L. [9 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA
[5] Christiana Care Hlth Syst Inc, Newark, DE USA
[6] Univ Maryland, Med Syst, Dept Med, Baltimore, MD 21201 USA
[7] Albert Einstein Coll Med, Bronx, NY USA
[8] Montefiore Med, Bronx, NY USA
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2020年 / 9卷 / 20期
基金
美国国家卫生研究院;
关键词
cardiac magnetic resonance imaging; heart failure; risk stratification; sudden cardiac death; ventricular arrhythmia; VENTRICULAR EJECTION FRACTION; SUDDEN CARDIAC DEATH; HEART-FAILURE; MAGNETIC-RESONANCE; MYOCARDIAL RECOVERY; SURVIVAL; ARRHYTHMIAS; MADIT; IDENTIFY; PATIENT;
D O I
10.1161/JAHA.120.017002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Current approaches fail to separate patients at high versus low risk for ventricular arrhythmias owing to overreliance on a snapshot left ventricular ejection fraction measure. We used statistical machine learning to identify important cardiac imaging and time-varying risk predictors. Methods and Results Three hundred eighty-two cardiomyopathy patients (left ventricular ejection fraction <= 35%) underwent cardiac magnetic resonance before primary prevention implantable cardioverter defibrillator insertion. The primary end point was appropriate implantable cardioverter defibrillator discharge or sudden death. Patient characteristics; serum biomarkers of inflammation, neurohormonal status, and injury; and cardiac magnetic resonance-measured left ventricle and left atrial indices and myocardial scar burden were assessed at baseline. Time-varying covariates comprised interval heart failure hospitalizations and left ventricular ejection fractions. A random forest statistical method for survival, longitudinal, and multivariable outcomes incorporating baseline and time-varying variables was compared with (1) Seattle Heart Failure model scores and (2) random forest survival and Cox regression models incorporating baseline characteristics with and without imaging variables. Age averaged 57 +/- 13 years with 28% women, 66% white, 51% ischemic, and follow-up time of 5.9 +/- 2.3 years. The primary end point (n=75) occurred at 3.3 +/- 2.4 years. Random forest statistical method for survival, longitudinal, and multivariable outcomes with baseline and time-varying predictors had the highest area under the receiver operating curve, median 0.88 (95% CI, 0.75-0.96). Top predictors comprised heart failure hospitalization, left ventricle scar, left ventricle and left atrial volumes, left atrial function, and interleukin-6 level; heart failure accounted for 67% of the variation explained by the prediction, imaging 27%, and interleukin-6 2%. Serial left ventricular ejection fraction was not a significant predictor. Conclusions Hospitalization for heart failure and baseline cardiac metrics substantially improve ventricular arrhythmic risk prediction.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication
    Schaer, Beat
    Kuehne, Michael
    Reichlin, Tobias
    Osswald, Stefan
    Sticherling, Christian
    EUROPACE, 2016, 18 (02): : 227 - 231
  • [2] Clinical predictors of appropriate implantable-cardioverter defibrillator discharge
    Catanzaro, John N.
    Makaryus, Amgad N.
    Sison, Cristina
    Vavasis, Christos
    Donaldson, David
    Beldner, Stuart
    Boal, Bernard
    Jadonath, Ram
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2007, 30 : S120 - S124
  • [3] Myeloperoxidase and brain natriuretic peptide levels as predictors of appropriate implantable cardioverter defibrillator therapy
    Burke, Peter T.
    CIRCULATION, 2006, 113 (21) : E799 - E799
  • [4] Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy
    Rankovic, V
    Karha, J
    Passman, R
    Kadish, AH
    Goldberger, JJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (09): : 1072 - 1076
  • [5] APPROPRIATE AND INAPPROPRIATE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: INCIDENCE AND PREDICTORS
    Min, David B.
    Masri, Ahmad
    Popovic, Zoran
    Kanj, Mohamed
    Smedira, Nicholas
    Lytle, Bruce
    Thamilarasan, Maran
    Lever, Harry
    Desai, Milind
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A319 - A319
  • [6] Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery in ischemic and nonischemic cardiomyopathy
    Ribeiro, V.
    Melao, F.
    Dias, P.
    Vasconcelos, M.
    Mota Garcia, R.
    Frutuoso, C.
    Maciel, Mj
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 46 - 47
  • [7] Predictors of appropriate implantable cardioverter defibrillator therapy in the multi-center unsustained tachycardia trial
    Al-Khatib, SM
    Hafley, GE
    Lee, KL
    Buxton, AE
    CIRCULATION, 2004, 110 (17) : 503 - 503
  • [8] PREDICTORS OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
    Singh, Sajya
    Thomas, Aaron
    Casey, Sue
    Storey, Katelyn
    Kunz, Miranda
    Berg, Allison
    Katsiyiannis, William
    Abdelhadi, Raed
    Bennett, Mosi
    Sengupta, Jay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 488 - 488
  • [9] Upgrade of implantable cardioverter-defibrillator to cardiac resynchronization therapy: rate of progression and baseline predictors
    Sumner, G. L.
    Sheldon, R.
    Cassidy, P.
    Gillis, A.
    Exner, D.
    Quinn, R.
    Veenhuysen, G.
    Duff, H.
    Kavanagh, K.
    Mitchell, B.
    EUROPEAN HEART JOURNAL, 2009, 30 : 420 - 420
  • [10] Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
    Ahmed, Imdad
    Nelson, William B.
    House, Chad M.
    Zhu, Dennis W. X.
    HEART INTERNATIONAL, 2010, 5 (01): : 16 - 19